Literature DB >> 25883257

Mucosal pigmentation of the hard palate in a patient taking imatinib.

Alexandra Lyne1, Alex Creedon1, Basil Malcolm West Bailey1.   

Abstract

Imatinib mesylate is used in the treatment of chronic myeloid leukaemia, among other conditions. Oral mucosal pigmentation as a side effect is rare. We present a summary of the current literature and a case report of a 58-year-old Caucasian woman who presented with a diffuse blue-grey pigmentation of the palatal mucosa, thought to be related to long-term use of imatinib mesylate. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25883257      PMCID： PMC4420804          DOI： 10.1136/bcr-2015-209335

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN： 1757-790X


  10 in total

Review 1.  Oral melanosis after tyrosine kinase inhibition with Imatinib for chronic myelogenous leukemia: report of a case and review of the literature.

Authors:  Michelle Wong; Shachar Sade; Melanie Gilbert; Hagen B E Klieb
Journal:  Dermatol Online J       Date:  2011-05-15

2.  Pigmentary changes in chronic myeloid leukemia patients treated with imatinib mesylate.

Authors:  B Arora; L Kumar; A Sharma; J Wadhwa; V Kochupillai
Journal:  Ann Oncol       Date:  2004-02       Impact factor: 32.976

3.  Imatinib-induced dental hyperpigmentation in childhood chronic myeloid leukemia.

Authors:  Navdeep Singh; Sameer Bakhshi
Journal:  J Pediatr Hematol Oncol       Date:  2007-03       Impact factor: 1.289

4.  Imatinib-associated hyperpigmentation, a side effect that should be recognized.

Authors:  T Mcpherson; V Sherman; R Turner
Journal:  J Eur Acad Dermatol Venereol       Date:  2008-04-01       Impact factor: 6.166

5.  Diffuse pigmentation of the palate.

Authors:  David M Lewis
Journal:  J Okla Dent Assoc       Date:  2009-11

6.  Imatinib mesylate-induced hyperpigmentation of the nose and palate.

Authors:  Hyo Sang Song; Hee Young Kang
Journal:  Ann Dermatol       Date:  2014-07-31       Impact factor: 1.444

7.  Mucosal pigmentation caused by imatinib: report of three cases.

Authors:  Chia-Cheng Li; Salman M Malik; Bart F Blaeser; Walid J Dehni; Sadru P Kabani; Niamh Boyle; Mary Toner; Sook-Bin Woo
Journal:  Head Neck Pathol       Date:  2011-12-31

8.  Imatinib-associated hyperpigmentation of the palate in post-HSCT patient.

Authors:  Renata Gonçalves Resende; Raissa Gabriela Lopes Teixeira; Fabiana de Oliveira Vasconcelos; Maria Elisa de Souza Silva; Mauro Henrique Guimarães Abreu; Ricardo Santiago Gomez
Journal:  J Craniomaxillofac Surg       Date:  2011-09-08       Impact factor: 2.078

Review 9.  Pigmented lesions of the oral cavity: review, differential diagnosis, and case presentations.

Authors:  Adel Kauzman; Marisa Pavone; Nick Blanas; Grace Bradley
Journal:  J Can Dent Assoc       Date:  2004-11       Impact factor: 1.316

10.  Oral pigmentation in the hard palate associated with imatinib mesylate therapy: a report of three cases.

Authors:  U Mattsson; S Halbritter; E Mörner Serikoff; L Christerson; G Warfvinge
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2011-02-16
  10 in total
  2 in total

Review 1.  Medication-Induced Oral Hyperpigmentation: A Systematic Review.

Authors:  Nada O Binmadi; Maram Bawazir; Nada Alhindi; Hani Mawardi; Ghada Mansour; Sana Alhamed; Sarah Alfarabi; Sara Akeel; Soulafa Almazrooa
Journal:  Patient Prefer Adherence       Date:  2020-10-15       Impact factor: 2.711

2.  Hyperpigmentation of the hard palate mucosa in a patient with chronic myeloid leukaemia taking imatinib.

Authors:  Gian Paolo Bombeccari; Umberto Garagiola; Francesco Pallotti; Margherita Rossi; Massimo Porrini; Aldo Bruno Giannì; Francesco Spadari
Journal:  Maxillofac Plast Reconstr Surg       Date:  2017-12-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.